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IntroductIon
Neisseria gonorrhoeae is a strict human pathogen that has caused 
the sexually transmitted disease gonorrhea for thousands of years 
(Sparling et al., 1990). Over the millennia, gonococci have devel-
oped a number of mechanisms to escape both innate and adaptive 
immune responses of the human host, which likely explains why 
immunity to re-infection does not occur. The ability of gonococci 
to alter the structure of a number of surface antigens or to variably 
produce them or to express surface structures that are similar to 
host antigens (“molecular mimicry”) have been invoked (Sparling 
et al., 1990) as mechanisms by which this pathogen evades both 
innate and adaptive host defense systems.
We are interested in the genetic basis for how gonococci can 
evade antimicrobial agents that it encounters during infection 
of mucosal surfaces or when growing in the bloodstream. In this 
respect, our previous work showed that the MtrC-MtrD-MtrE 
efflux pump can export host-derived antimicrobial agents such as 
Lipooligosaccharide structure is an important determinant in 
the resistance of Neisseria gonorrhoeae to antimicrobial 
agents of innate host defense
Jacqueline T. Balthazar1,2, Asiya Gusa2, Larry E. Martin1,3, Biswa Choudhury4†, Russell Carlson4 and 
William M. Shafer1,2*
1 Laboratories of Bacterial Pathogenesis, VA Medical Research Service, VA Medical Center, Decatur, GA, USA
2 Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA
3 Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
4 Complex Carbohydrate Research Center, University of Georgia, Athens, GA, USA
The strict human pathogen Neisseria gonorrhoeae has caused the sexually transmitted infection 
termed gonorrhea for thousands of years. Over the millennia, the gonococcus has likely evolved 
mechanisms to evade host defense systems that operate on the genital mucosal surfaces in both 
males and females. Past research has shown that the presence or modification of certain cell 
envelope structures can significantly impact levels of gonococcal susceptibility to host-derived 
antimicrobial compounds that bathe genital mucosal surfaces and participate in innate host 
defense against invading pathogens. In order to facilitate the identification of gonococcal genes 
that are important in determining levels of bacterial susceptibility to mediators of innate host 
defense, we used the Himar I mariner in vitro mutagenesis system to construct a transposon 
insertion library in strain F62. As proof of principle that this strategy would be suitable for 
this purpose, we screened the library for mutants expressing decreased susceptibility to the 
bacteriolytic action of normal human serum (NHS). We found that a transposon insertion in 
the lgtD gene, which encodes an N-acetylgalactosamine transferase involved in the extension 
of the α-chain of lipooligosaccharide (LOS), could confer decreased susceptibility of strain 
F62 to complement-mediated killing by NHS. By complementation and chemical analyses, 
we demonstrated both linkage of the transposon insertion to the NHS-resistance phenotype 
and chemical changes in LOS structure that resulted from loss of LgtD production. Further 
truncation of the LOS α-chain or loss of phosphoethanolamine (PEA) from the lipid A region of 
LOS also impacted levels of NHS-resistance. PEA decoration of lipid A also increased gonococcal 
resistance to the model cationic antimicrobial polymyxin B. Taken together, we conclude that 
the Himar I mariner in vitro mutagenesis procedure can facilitate studies on structures involved 
in gonococcal pathogenesis.
Keywords: Neisseria gonorrhoeae, mutagenesis, complement, antimicrobial, peptide, resistance, lipooligosaccharide
cationic antimicrobial peptides (CAPs; Shafer et al., 1998), as well 
as certain classical antibiotics (Veal et al., 2002). In addition to 
energy-dependent efflux, gonococcal resistance to CAPs has been 
linked to the decoration of lipid A by phosphoethanolamine (PEA; 
Lewis et al., 2009), which likely interferes with the ability of CAPs 
to bind to negatively charged groups on the bacterial surface.
In order to identify additional gonococcal determinants impor-
tant for bacterial resistance to host-derived antimicrobials, we 
constructed a Himar I mariner transposon (Pelicic et al., 2000) 
mutant library of strain F62. We screened this library for mutants 
expressing decreased susceptibility to normal human serum (NHS) 
because the ability of gonococci to escape such killing is of likely 
importance in its capacity to proliferate if it enters the blood stream 
or if it encounters lethal levels of complement components and 
natural antibody at mucosal surfaces (Schoolnik et al., 1976; Rice 
et al., 1980; Rice, 1989; Shafer et al., 1982, 1984) Since NHS kill-
ing of strain F62 (and other NHS-sensitive gonococci) can be 
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constructIon and analysIs of a Himar i mariner mutant 
lIbrary of straIn f62 and IsolatIon and molecular 
characterIzatIon of an nhs-resIstant mutant
Himar I transposase was purified (Pelicic et al., 2000) and used for 
in vitro transposition reactions with bulk DNA purified from strain 
F62, as described previously (Alexander et al., 2006). The transposi-
tion reaction mixture was used to transform piliated strain F62, as 
described previously (Gunn and Stein, 1996), and transformants 
were selected on GCB agar plates containing 100 μg of kanamycin 
(Kan)/mL. This procedure was repeated until a total of 10,000 trans-
formants were obtained. All transformants were passed on GCB 
agar containing Kan and then resuspended in 100 μl of freezing 
media in 96 well microtiter plates and stored at −80°C. A pool of the 
library was also made and similarly stored. In order to determine 
whether random insertion of the Himar I transposon was achieved, 
DNA was prepared from 20 mutants. The DNA preparations were 
digested with ClaI and subjected to agarose gel electrophoresis fol-
lowed by Southern hybridization analysis (Southern, 1975) using 
the aphA-3 gene as a transposon-specific probe (Pelicic et al., 2000). 
The results showed that the DNA from these mutants had a single 
insertion and that the insertion was in distinct ClaI fragments (data 
not presented).
In order to isolate Himar I mutants of F62 expressing decreased 
susceptibility to NHS, the library was grown overnight on GCB agar 
plates containing Kan at 37°C under 3.8% (v/v) C0
2
. The growth 
was removed and used to inoculate 50 mL. of GCB broth with sup-
plements and grown as described above to late-logarithmic phase. 
The culture was diluted 10-fold in 0.2× GCB broth and exposed to 
NHS [final concentration of 12.5% (v/v)] for 30 min and survivors 
were recovered by dilution plating onto GCB agar. This concentra-
tion of NHS was used because in preliminary experiments we found 
that use of a lower concentration of NHS resulted in inefficient kill-
ing and gave a high background of surviving gonococci that did not 
differ from parental strain F62 with respect to level of susceptibility 
to NHS (data not presented). After overnight growth, the colonies 
that survived in the presence of 12.5% NHS were pooled and re-
exposed to NHS as described above. This procedure was repeated 
for a third time and individual colonies were then screened along 
with parental strain F62 in the standard SBA. Ultimately, a mutant 
(WMS 100) that was less NHS-susceptible than parental strain F62 
was identified. DNA was prepared from this mutant and used to 
transform F62 for Kan resistance and 10 individual transformants 
were screened in the NHS assay, all of which expressed the NHS-
resistance profile of the original mutant.
Ligation-polymerase chain reaction (PCR) and DNA sequencing was 
used to map the site of the transposon insertion as described previously 
(Pelicic et al., 2000). The oligonucleotide primers used for the ligation-
PCR were LMP1, LMP2, and IR1 (Pelicic et al., 2000). DNA sequenc-
ing was performed on a PCR product from a pBAD construct that 
contained the ligation-PCR product. This PCR product was sequenced 
using primer LGT19 (5′-GCGGTATTTGACCAAGGCTTC-3′) and 
IR1 (Pelicic et al., 2000).
constructIon of lgta and lpta InsertIonal mutants
Transformants of strain F62 bearing inactivated lgtA and/or 
lptA genes were constructed by transformation using donor 
DNA from strains FA19 lgtA::km or FA19 lptA::spc, which have 
potent, we hypothesized that it could be used to directly select 
 transposon-facilitated NHS-resistant mutants in a library of sus-
ceptible bacteria. NHS killing of gonococci is principally mediated 
by an antibody-dependent (IgM) mechanism involving the classical 
complement pathway (CCP; Shafer et al., 1982, 1984, 2002; Rice, 
1989). While most strains of gonococci are NHS-sensitive, some 
strains can display a stable NHS-resistance phenotype and they are 
more frequently isolated from patients with disseminated gonococ-
cal infection (DGI; Schoolnik et al., 1976, Rice et al., 1980). Stable 
NHS-resistance expressed by these gonococci has been associated 
with the production of a certain serotype of the major outer mem-
brane porin (Por1A vs. Por1B; Cannon et al., 1983; Rice, 1989; Ram 
et al., 1998; Ram, 2001), production of a 3.6-kDa lipooligosaccha-
ride (LOS; Schneider et al., 1985; Shafer et al., 2002), and decoration 
of lipid A by PEA (Lewis et al., 2009).
In the present study we obtained additional evidence that LOS 
structure is important in determining whether gonococci can resist 
killing by NHS. This was surmised because a stable Himar I mari-
ner transposon insertion in a gene (lgtD) encoding a glycosyltrans-
ferase that adds N-acetyl-galactosamine (GalNAc) to the terminal 
galactose in the LOS α-chain rendered strain F62 less susceptible 
to such killing. lgtD is a phase variable gene within the lgtABCDE 
operon that switches from phase-on to phase-off (and vice versa) at 
high frequencies due to a homopolymeric repeat within the coding 
sequence (Gotschlich, 1994). This mutant encouraged us to more 
closely evaluate the role of LOS in determining the ability of strain 
F62 to resist host defensive agents. Importantly, this work shows that 
the Himar I mariner transposon mutagenesis procedure, previously 
employed with success in Neisseria meningitidis (Pelicic et al., 2000), 
can be used to study mechanisms of pathogenesis in gonococci.
materIals and methods
bacterIal straIns, culture condItIons, and bacterIcIdal 
assays
Neisseria gonorrhoeae strain F62, which was kindly provided by S. 
Morse (Centers for Disease Control and Prevention, Atlanta, GA, 
USA), was the primary strain employed in this study and was cul-
tured from a lyophilized stock prepared by Kellogg in 1962 (Kellogg 
et al., 1963). It was routinely cultured on GCB agar plates containing 
defined supplements I and II (Shafer et al., 1982) in 3.8% (v/v) CO
2
 at 
37°C as a piliated (P+), opacity-negative (Opa−) variant for transfor-
mation experiments and as a P− Opa− variant for serum bactericidal 
assays (SBA). The SBA employed pooled NHS and heat-inactivated 
NHS (∆NHS), as described previously (Shafer et al., 1982). Gonococci 
were incubated with serum samples for 45 min at 37°C prior to plat-
ing onto GCB agar. In this assay, NHS-resistance is defined as >30% 
survival calculated on the input (105 cfu) of gonococci in the reaction 
mixture. Naturally NHS-resistant strain FA19 was used as a control 
since it can survive in 50% (v/v) NHS concentrations (Shafer et al., 
1982, 2002). All assays were repeated in triplicate and the data were 
calculated as average values ± SD. The significance of the results was 
determined by Student’s t-test. Serum was obtained by venipuncture 
from healthy volunteers after written informed consent and the col-
lection of such serum was approved by the Institutional Review Board 
of Emory University. The agar dilution method for determining the 
minimal inhibitory concentration (MIC) for polymyxin B (PMB) 
was as described previously (Lewis et al., 2009).
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were extracted with a 9:1 ethanol–water mixture and then lyophi-
lized. The oligosaccharides (OSs) were released from the LOS by 
mild acid hydrolysis [1% (v/v) acetic acid at 100°C for 2 h]. The 
lipid A portions were precipitated by low-speed centrifugation, 
and supernatants containing the OS fraction were lyophilized and 
used for chemical and structural analyses as described (Shafer et al., 
2002; Lewis et al., 2009). The OSs were treated with 48% hydrogen 
fluoride (HF) at 4°C for 48 h to remove any phosphate groups; e.g., 
phosphate or PEA. The HF-treated material was neutralized by 
ice-cold ammonium hydroxide solution (approximately 30%) on 
an ice-water bath. The neutralized material was desalted by gel per-
meation chromatography using fine grade Bio-Gel P2 (Bio-Rad).
Glycosyl compositional analysis was performed by gas 
 chromatography–mass spectrometry (GLC–MS) of trimethylsi-
lyl (TMS) methyl glycosides with myoinositol used as an internal 
standard (York et al., 1985). The samples were hydrolyzed with 
methanolic 1 M HCl at 80°C for 18 h. The released monosaccha-
rides were dried under a stream of dry air and N-acetylated with 
3:1:1 methanol/pyridine/acetic anhydride (v/v/v) at 100°C for 1 h. 
After cooling, samples were dried-down and trimethylsilylated with 
Tri-sil reagent (Pierce) for 30 min at 80°C. The resulting TMS deriv-
atives were analyzed by GLC–MS, on Hewlett–Packard HP5890/
HP5970 MSD gas chromatograph/mass spectrometer equipped 
with Supelco DB-1 fused silica capillary column (30 m × 0.25 mm 
I.D.) with helium as the carrier gas.
Linkage analyses were carried out by the slurry NaOH method 
modified from that of Ciucanu and Kerek (1984). Samples were 
dissolved in 0.5 mL dimethyl sulfoxide (DMSO) by stirring over-
night at room temperature under a N
2
 atmosphere. After disso-
lution, a freshly prepared slurry of NaOH in DMSO was added 
(0.5 mL) and the reaction mixture was stirred for 2 h at room 
temperature. Methylation was performed by the sequential addition 
of iodomethane (250 μL followed by 100 μL) at 30 min intervals. 
The permethylated monosaccharide was extracted into the organic 
phase after partitioning the reaction mixture between water and 
chloroform. The organic phase was then removed by evaporation 
under a stream of N
2
. The permethylated OS was hydrolyzed with 
4 M TFA (100°C, 6 h), reduced with NaBH
4
, acetylated and the 
resulting partially methylated alditol acetates (PMAAs) were dis-
solved in dichloromethane and analyzed by GLC/MS using an HP-1 
(from Hewlett–Packard) capillary column (25 m × 0.25 mm).
Oligosaccharides were analyzed by matrix-assisted laser desorp-
tion ionization–time of flight mass spectrometry (MALDI–TOF MS) 
using a 4700 Proteomics Analyzer instrument (Applied Biosystems). 
The OS samples were dissolved in water (1 μg/μL), mixed in a 1:1 
(v/v) ratio with 0.5 M 2,5-dihydroxybenzoic acid (DHB) in metha-
nol matrix solution, and spotted on a stainless steel MALDI plate. 
Spectra were acquired in both the positive and negative acquisition 
modes. The acceleration voltage was set to 20 kV and data were 
acquired in the reflectron mode with a 200-ms delay.
results
IsolatIon of a Himar i InsertIon mutant of straIn f62 wIth 
decreased nhs-susceptIbIlIty
We employed strain F62 in this investigation for a number of 
important reasons. First, it was originally employed in the early 
1960s for the development of a gonococcal typing scheme that 
been described (Shafer et al., 2002; Lewis et al., 2009). The lgtA 
mutation were confirmed by PCR using oligonucleotide prim-
ers LGT5 (5′-CCGGCCTGATTCCCTCTTTAA-3′) and LGT8 
(5′-CCGGCAGTTCATACGCCGCT-3′). The lptA mutation was 
confirmed using LPTA4 (5′-GGCGGAAGGCTTTGGAAAAC-3′) 
and LPTA5 (5′-GGCGAGTGCCTCGACA ATAT-3′).
complementatIon analysIs
The pGCC4 complementation vector described previously (Skaar 
et al., 2002) was used for complementation of the lgtD::km mutation 
generated by Himar I mariner mutagenesis. lgtD was PCR-amplified 
from genomic DNA using oligonucletotide primers that contained 
a PacI site (LGT15PAC; 5′-TTAATTAAGCCGTCTGAAGCCT-3′; 
restriction site is underlined) or PmeI site (LGT16Pme; 
5′-GTTTAAACGCGGAACGGAAGC-3′) and cloned into PacI–PmeI 
digested pGCC4. The plasmid construct, which contains an IPTG-
inducible lacZ promoter (Skaar et al., 2002) was purified and used to 
transform strain WMS 100 (see Table 1) for resistance to chloramphen-
icol (1 μg/mL). The insert, positioned between the lctP and aspC chro-
mosomal sites (Skaar et al., 2002; Folster et al., 2009), was verified by 
PCR using primers LGT23 (5′-CGGCTGGATTGAGAAAATCGT-3′) 
and LCTP (5′-GCGCGATCGGTG CGTTCT-3′). Expression of the 
insert was performed by growing the complemented strain (WMS 
101) in GCB broth or on GCB agar containing 1 mM IPTG as described 
previously (Folster et al., 2009). RT-PCR (Folster et al., 2009) was 
performed to confirm expression of the ectopically expressed lgtD 
gene in WMS 101. The lptA::spc mutation was complemented using 
the previously described (Lewis et al., 2009) pGCC4 construct that 
contained the wild type gene.
los chemIcal analyses
Lipooligosaccharide produced by gonococcal strains were visu-
alized by subjecting proteinase K digests of whole cell lysates to 
Tricine SDS-PAGE (Lesse et al., 1990) followed by silver staining 
(Tsai and Frasch, 1982), or Western immunoblotting (Towbin et al., 
1979) using anti-LOS monoclonal antibodies 4C4, 3F11, or 1-1-M 
as described (Gotschlich, 1994; Shafer et al., 2002), which recognize 
epitopes in the α-chain of the core oligosaccharide.
Lipooligosaccharide was purified from 12 L batch cultures 
of strains grown in GCB broth with defined supplements I and 
II under 3.8% CO
2
 as described (Lewis et al., 2009). In order to 
remove contaminating phospholipids the dried bacterial pellets 
Table 1 | Description and susceptibility of strains to NHS and PB.
Strain Genotype % Survival in PB MIC (μg/mL) 
  12.5% NHS
F62 Wild type 2.15 (±1.24) 50
WMS 100 F62 lgtD::km 51.8 (±18.1)* 50
WMS 101 WMS 100 lgtD+ 1.65 (±1.45)** 50
WMS 102 F62 lgtA::km 87.2 (±7.05)* 50
WMS 103 WMS 100 lptA::spc 2.37 (±2.17)** 0.2
WMS 104 F62 lptA::spc ND 0.2
WMS 105 WMS 104 lptA+ ND 50
*p < 0.001 compared to F62; **p < 0.001 compared WMS 100.
ND, not determined.
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LOS species produced by these strains by subjecting proteinase 
K digests of their whole cell lysates to SDS-PAGE. Silver staining 
of the gels revealed that F62 and complemented strain WMS 101 
produced two in predominant LOS species (data not presented 
but summarized in Table 2) that migrated at 4.5 and 4.8 kDa. 
In contrast, mutant strain WMS 100 produced a single LOS spe-
cies that migrated at 4.5 kDa. The 4.5-kDa species was reactive 
with mAb 3F11 (which recognizes Gal-GlcNAc-Gal-Glc-HepI), 
while the 4.8-kDa species was reactive with mAb 1-1-M (which 
recognizes GalNAc-Gal-GlcNAc-Gal-Glc-HepI; Table 2); neither 
of these species bound mAb 4C4, which recognizes Gal-Glc-HepI 
in the 3.6-kDa species previously linked to stable NHS-resistance 
in strain FA19 (Shafer et al., 2002). Based on earlier LOS-epitope 
mapping experiments, the electrophoretic mobility of the LOS 
species, the reported structure of F62 LOS species (Yamasaki 
et al., 1991) and the deduced N-acetylgalactosamine transferase 
activity of LgtD (Gotschlich, 1994), we hypothesized that the LOS 
produced by F62 and WMS 100 would differ by the absence of a 
terminal N-acetylgalactosamine in the α-chain. Indeed, chemical 
and structural analyses (Figure 1; Table 3) of the LOS produced 
by F62 and WMS 100 confirmed this inference.
For structural analysis the OSs from F62 and WMS 100 LOSs 
were treated with aqueous HF to remove any phosphate groups, 
as described in the Methods, in order to facilitate glycosyl com-
position and linkage analyses as well as MS analysis of the OSs. 
Glycosyl composition analysis of the HF-treated OS fraction from 
wild type F62 showed the presence of glucose (Glc), galactose 
(Gal), N-acetylglucosamine (GlcNAc), N-acetylgalactosamine 
(GalNAc), heptose (Hep), and 3-deoxy-d-manno-2-octulosonic 
acid (Kdo). Composition analysis of the HF-treated OS from the 
lgtD::km mutant strain (WMS 100) showed the same glycosyl 
components with the exception that GalNAc was not detected. 
Glycosyl linkage analysis showed that the F62 OS fraction con-
tained terminally linked GalNAc (t-GalNAc), t-Gal, t-GlcNAc, 
4-linked GlcNAc (4-GlcNAc), 4-Glc, 3-Gal, 2-Hep, and 3,4-Hep. 
The OS from mutant strain WMS 100 contained all of the same 
residues except that it was completely devoid of t-GalNAc and the 
t-Gal: 3-Gal ratio was increased.
The HF-treated OS fraction from each strain was subjected to 
MALDI–TOF MS analysis and the results are shown in Figure 1 and 
in Table 3. The wild type F62 OS fraction shows two ion clusters 
was based on the state of piliation (Kellogg et al., 1963; piliated T1 
and T2 vs. non-piliated T3 and T4 colony types). Second, it was 
employed in human experimental infection studies that identified 
pili as being important for establishing a gonococcal infection in 
male volunteers (Kellogg et al., 1968). Third, the LOS species it natu-
rally produces have been defined (Yamasaki et al., 1991). Finally, 
since it is highly sensitive to killing by NHS, which is mediated 
by an antibody (natural IgM)- and CCP-dependent mechanism 
(Shafer et al., 1982), we reasoned that the killing capacity of NHS 
would be sufficient to use it as a selective pressure when screening 
the transposon library.
In order to isolate stable transposon mutants of strain F62 in 
the Himar I mariner library bank that expressed decreased suscep-
tibility to NHS, the entire bank was grown in batch culture and 
exposed to 12.5% (v/v) serum. This process was repeated twice and 
ultimately a transposon mutant (WMS 100) expressing decreased 
susceptibility to NHS (average of 51.8% survival), compared to par-
ent strain F62 (average of 2.15 % survival), was identified (Table 1). 
A randomly picked Himar I mutant was used as a control in the 
NHS bactericidal assay and it was as NHS-susceptible as parent 
strain F62 (data not presented) indicating that the possession of 
the transposon per se was not responsible to the elevated NHS-
resistance displayed by WMS 100.
In order to locate the site of the transposon insertion in WMS 
100, we employed ligation-PCR and DNA sequencing (Pelicic 
et al., 2000). These procedures mapped the transposon inser-
tion to the 5′-end of the lgtD coding sequence between nucle-
otide positions 61 and 62 (data not presented). The lgtD gene 
is part of a five gene operon (lgtABCDE) and it, as well as lgtA 
and lgtC, are phase variable due to polymeric repeat sequences 
(Gotschlich, 1994; Yang and Gotschlich, 1996; Shafer et al., 2002). 
Due to the phase variable property of lgtD, it was not clear if the 
observed NHS-resistance property of WMS 100 was due to the 
transposon insertion or spontaneous mutation in other genes. 
To determine if transposon insertion within lgtD was responsible 
for the increased NHS-resistance property of strain WMS 100, 
DNA from this mutant was used to transform parent strain F62 
for KanR. Analysis of 10 individual transformants revealed that all 
expressed decreased susceptibility to NHS (data not presented) 
similar to WMS 100, indicating that the serum susceptibility 
phenotype was linked to the transposon insertion. Further veri-
fication that the transposon insertion in lgtD in WMS 100 was 
responsible for its decreased NHS-susceptibility phenotype was 
obtained by complementation analysis in which the wild type 
lgtD gene from parental strain F62 was expressed ectopically 
from the lctP–aspC region under the control of the lac promoter 
(Skaar et al., 2002). With complemented strain WMS 101, we 
found that expression of the wild type lgtD resulted in an NHS-
susceptible phenotype (average of 1.65 % survival) similar to 
strain F62 (Table 1).
characterIzatIon of los due to transposon InsertIon In lgtD
The major LOS species produced by strains F62 have been structur-
ally characterized (Yamasaki et al., 1991). Herein, we determined 
whether the LOS species produced by strain F62 would differ from 
WMS 100 and if those produced by complemented strain WMS 
101 would resemble that of F62. We first identified the major 
Table 2 | Lipooligosaccharide species produced by gonococcal strains.
Strain LOS Reactivity with 
 species (kDa) mAbs
  3F11 1-1-M 4C4
F62 4.5 + − −
 4.8 − + −
WMS 100 4.5 + − −
WMS 101 4.5 + − −
 4.8 − + −
WMS 102 3.6 − − +
Lipooligosaccharide species are given in kilodaltons (kDa) as determined by 
Tricine SDS-PAGE analysis.
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with the higher molecular weight cluster differing from the lower 
molecular weight cluster by 203 mass units, the mass of a HexNAc 
residue (Figure 1). Both ion clusters also contained masses that 
differed by 57 mass units; the mass of glycine (Gly) indicated that 
Gly-containing structures with and without a HexNAc residue 
were present. The WMS 100 mutant OS fraction showed a single 
ion cluster that contains the same ions as observed for the lower 
molecular weight ions present in the wild type F62 OS fraction; i.e., 
only those ions that lack a HexNAc residue are present in the WMS 
100 mutant OS. The proposed compositions, based on the glycosyl 
residue analysis described above, for the observed ions are shown in 
Table 3 together with the observed and calculated m/z values.
A
B
FIGuRe 1 | Matrix-assisted laser desorption ionization–time of flight mass spectra, which was obtained in the negative mode, of the HF-treated OS from 
strains F62 (A) and WMS 100 (B) LOS.
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importance of lgtA, we introduced a non-polar lgtA::km muta-
tion into strain F62 since LgtA is glycosyltransferase that adds 
GlcNAc to the terminal galactose in the α-chain of the 3.6-kDa 
LOS (Gotschlich, 1994; Shafer et al., 2002). A resulting lgtA::km 
transformant (WMS 102) was found to produce a single LOS 
species (3.6 kDa) that was reactive with mAb 4C4 (Table 2), but 
not 3F11 or 1-1-M. Importantly, WMS 102 expressed a level of 
NHS-resistance (average of 87.2% survival) that was substantially 
greater than that seen in the lgtD mutant WMS 100 (Table 1) or 
parental strain F62. However, incubation of WMS 102 (or WMS 
100) in higher concentrations (>25%) of NHS resulted in less sur-
vival (<1%) of gonococci, while a naturally NHS-resistant strain 
(FA19) showed complete resistance (>100% survival). Thus, trun-
cation of the LOS α-chain in F62 is not sufficient for complete 
NHS-resistance at higher serum levels presumably because it still 
possesses a Por1B protein as opposed to the Por1A produced by 
FA19 (Shafer et al., 2002). Nevertheless, since complement com-
ponents can be at reduced levels at mucosal surfaces (Rice, 1989), 
phase-variants of naturally NHS-sensitive gonococci that produce 
truncated LOS species due to spontaneous mutations in lgtA or 
lgtD would have a survival advantage against this mechanism of 
innate host defense.
loss of pea modIfIcatIon of lIpId a Increases nhs-
susceptIbIlIty of gonococcI
Having determined that the length of the LOS α-chain is important 
in determining levels of NHS-susceptibility expressed by strain 
F62, we next examined whether the structure of its lipid A can 
also contribute to resistance. In this respect, we recently showed 
(Lewis et al., 2009) that loss of 4´ PEA from lipid A due to a null 
mutation in lptA could render normally NHS-resistant strain FA19 
highly susceptible to NHS through a classical pathway-dependent 
mechanism. In order to test if such PEA modification of the lipid 
A was important in the ability of WMS 100 to express decreased 
susceptibility to NHS, we created an lptA::spc transformant (see 
strain WMS 103). The results (Table 1) showed that WMS 103 was 
substantially more NHS-susceptible (average of 1.3 % survival) 
than parent strain WMS 100. In fact, the lptA mutation negated the 
NHS-resistance profile afforded by the lgtD mutation. Thus, from 
our studies on the Himar I transposon mutant strain WMS 100, we 
conclude that both the length of the α-chain of the core oligosac-
charide and 4´ lipid A PEA are important LOS structures that can 
determine the extent of gonococcal susceptibility to NHS.
The complete structures of the OSs for the F62 LOS have been 
reported (Yamasaki et al., 1991). These structures are shown in 
Figure 2. Our glycosyl composition, linkage, and MS results are 
consistent with this report by Yamasaki et al. (1991), which shows 
that the F62 LOS contains the two OSs shown in Figure 2, one with 
a t-GalNAc residue and one that lacks this residue. The lack of the 
t-GalNAc residue in the LOS from mutant WMS 100, as well as the 
MS, glycosyl composition, and linkage analyses is consistent with 
the conclusion that this LOS contains the OS structure shown in 
Figure 2 that lacks the GalNAc residue and confirms that the lgtD 
gene encodes the GalNAc transferase.
productIon of a 3.6-kda los results In Increased nhs-
resIstance In straIn f62
Since our earlier work (Shafer et al., 2002) with the naturally NHS-
resistant strain FA19 revealed that production of a 3.6-kDa LOS 
species with the LOS α-chain, which consists of Gal-Glc-HepI, 
was important in NHS-resistance, we next asked if production 
of a similarly truncated LOS by normally highly NHS-sensitive 
F62 would result in a level of NHS-resistance greater than that 
expressed by lgtD mutant strain WMS 100. We addressed this 
matter because our screening of the transposon library for NHS-
resistant variants did not identify an insertion in lgtA, which 
based on our earlier work with strain FA19 (Shafer et al., 2002), 
is known to be important in NHS-resistance. In order to test the 
Table 3 | Ions, [M-H]−, observed on mass spectrometric analysis for the 
HF-treated oligosaccharides from wild type F62 and mutant WMS 100 
lipooligosaccharides.
Obs. mass Cal. mass Proposed F62 WMS 100 
  composition
1556.9 1556.5 Gal2GlcGlcNAc2
 + +
  Hep2.KdoOAc
1614.0 1613.6 Gal2GlcGlcNAc2 + +
  Hep2.KdoOAcGly
1514.8 1514.4 Gal2GlcGlcNAc2Hep2.Kdo
 + +
1496.8 1496.4 Gal2GlcGlcNAc2Hep2.
 + +
  Kdo (anhydro)
1571.9 1571.5 Gal2GlcGlcNAc2Hep2.KdoGly + +
1553.9 1553.5 Gal2GlcGlcNAc2Hep2. + +
  KdoGly (anhydro)
1760.1 1759.7 GalNAcGal2GlcGlcNAc2 + −
  Hep2KdoOAc
1817.2 1816.8 GalNAcGal2GlcGlcNAc2 + −
  Hep2KdoOAcGly
1718.1 1717.7 GalNAcGal2GlcGlc + −
  NAc2Hep2Kdo
1775.2 1774.7 GalNAcGal2GlcGlcNAc2 + −
  Hep2KdoGly
1757.1 1756.7 GalNAcGal2GlcGlcNAc2 + −
  Hep2KdoGly (anhydro)
Shown are the observed (obs.) and calculated (cal.) masses for each OS species 
in strains.
F62 and WMS 100 with presence (+) or absence (−) of species designated.
FIGuRe 2 | The structures of the oligosaccharides reported by Yamasaki 
et al. (1991) for the LOS from strain F62. The composition, linkage, and MS 
results obtained in this report for F62 are consistent with these two structures 
and also with the conclusion that the lgtD mutant, WMS 100, contains only 
structure 2 which lacks the GalNAc residue.
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los structure and cap susceptIbIlIty expressed by gonococcI
Cationic antimicrobial peptides are on the first line of innate host 
defense and can kill microbes directly by damaging their mem-
branes or inhibiting intracellular processes (Brogden, 2005). They 
also indirectly kill microbes by virtue of their immunostimula-
tory, proinflammatory activities (Easton et al., 2009). Substantial 
evidence exists that alterations in lipid A structure can modulate 
levels of bacterial susceptibility to CAPs (Lee et al., 2004; Lewis 
et al., 2009). Accordingly, we tested if the LOS mutants described 
above would differ from parental strain F62 in their susceptibility 
to PMB, a model CAP. Although truncation of the LOS α-chain 
did not greatly influence the susceptibility of strain F62 to PMB, 
the presence of the lptA::spc mutation rendered strain F62 hyper-
susceptible to PMB (250-fold compared to parent strain F62; 
Table 1). Complementation of the mutant with the wild type lptA 
gene expressed from the lacZ promoter enhanced PMB-resistance 
by >60-fold (Table 1).
dIscussIon
A long-standing interest in gonococcal research has been to identify 
and characterize the molecular mechanisms that explain how this 
strict human pathogen can resist innate and adaptive immunity 
systems. We have been interested in how the gonococcus can evade 
killing by the complement system and host defense peptides (e.g., 
CAPs). In previous studies, we and others identified genes of inter-
est and constructed directed mutations for subsequent testing in 
antimicrobial assays. While this has proven to be a useful strategy, 
it is in fact biased for a select panel of genes. We have wanted an 
unbiased approach so that the killing power of host defense sys-
tems could be used to directly identify such mutants. To facilitate 
this effort, we employed the Himar I mariner in vitro transposon 
mutagenesis system for isolation of mutants of N. gonorrhoeae that 
manifest decreased susceptibility to complement-mediated killing 
by NHS. Through this strategy and with follow-up studies using 
gene-directed mutagenesis, we found that historically important 
strain F62 has LOS-dependent susceptibility to two components 
of innate host defense: the bactericidal action of NHS and CAPs. 
In this respect, the results presented herein and elsewhere (Shafer 
et al., 2002; Lewis et al., 2009) show that changes in the extension of 
the LOS α-chain, which can occur at high frequencies due to phase 
variable expression of genes in the lgtABCDE operon (Gotschlich, 
1994; Yang and Gotschlich, 1996), can determine levels of gonococ-
cal susceptibility to NHS (Shafer et al., 2002) while PEA decoration 
of lipid A is important in CAP-resistance (Lewis et al., 2009).
Normal human serum-resistance in gonococci has been linked to 
the serovar of the major outer membrane porin (Por1A vs. Por1B) 
produced. Por1B-producing gonococci are more frequently killed 
by NHS than Por1A strains. There is growing evidence, however, 
that the structure of LOS is important in NHS-resistance (Shafer 
et al., 2002; Ram et al., 2003) and other pathogenic steps used by 
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